Table 1 Baseline demographics of the PCV and control groups.

	PCV (n = 32)	Control (n = 30)	P value
Age, years	68.5 ± 9.8	64.8 ± 5.0	0.114^a
Sex, n (%)			0.567^b
Male	22 (68.8%)	21 (70.0%)
Female	10 (31.3%)	9 (30.0%)
Refractive error, diopter	0.24 ± 1.69	0.59 ± 0.96	0.549^a
Baseline BCVA, logMAR	0.51 ± 0.34	0.06 ± 0.08	< 0.001^a
Baseline CMT, µm	417.97 ± 130.15	273.00 ± 45.59	< 0.001^a
SFCT, µm	316.72 ± 94.49	232.05 ± 63.43	0.001^a
Haller’s layer	242.50 ± 91.76	141.05 ± 36.51	< 0.001^a
Choriocapillaris-Sattler's layer	74.22 ± 22.68	91.00 ± 38.72	0.181^a
Choroidal vascular area, mm²	140.20 ± 19.25	132.44 ± 17.56	0.109^a
Macular region (< 3 mm)	7.30 ± 0.60	6.85 ± 0.71	0.030^a
Near-peripheral region (3 ~ 10 mm)	67.21 ± 6.83	60.80 ± 7.68	0.003^a
Mid-peripheral region (10 ~ 15 mm)	54.04 ± 14.75	52.63 ± 12.82	0.549^a
Far-peripheral region (> 15 mm)	11.65 ± 9.72	12.17 ± 9.83	0.881^a
Choroidal vascular density, %	27.15 ± 1.86	25.17 ± 2.05	0.002^a
Macular region (< 3 mm)	25.80 ± 2.12	24.22 ± 2.50	0.029^a
Near-peripheral region (3 ~ 10 mm)	25.72 ± 1.98	23.43 ± 1.98	< 0.001^a
Mid-peripheral region (10 ~ 15 mm)	28.67 ± 2.40	26.95 ± 2.49	0.024^a
Far-peripheral region (> 15 mm)	29.39 ± 2.26	26.94 ± 3.51	0.010^a

^aMann-Whitney test, ^bPearson’s chi square test.
BCVA, best-corrected visual acuity; CMT, central macular thickness; PCV, polypoidal choroidal vasculopathy; SFCT, subfoveal choroidal thickness.

Quick links

Search